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154 | Chem. Sci., 2020, 11, 154–168ir inﬂuence on the development of
computer assisted synthesis planning tools in the
pharmaceutical domain†
Amol Thakkar, *ab Thierry Kogej,a Jean-Louis Reymond, b Ola Engkvista
and Esben Jannik Bjerrum *a
Computer Assisted Synthesis Planning (CASP) has gained considerable interest as of late. Herein we
investigate a template-based retrosynthetic planning tool, trained on a variety of datasets consisting of
up to 17.5 million reactions. We demonstrate that models trained on datasets such as internal Electronic
Laboratory Notebooks (ELN), and the publicly available United States Patent Oﬃce (USPTO) extracts, are
suﬃcient for the prediction of full synthetic routes to compounds of interest in medicinal chemistry. As
such we have assessed the models on 1731 compounds from 41 virtual libraries for which experimental
results were known. Furthermore, we show that accuracy is a misleading metric for assessment of the
policy network, and propose that the number of successfully applied templates, in conjunction with the
overall ability to generate full synthetic routes be examined instead. To this end we found that the
speciﬁcity of the templates comes at the cost of generalizability, and overall model performance. This is
supplemented by a comparison of the underlying datasets and their corresponding models.Introduction
Developments in computer assisted synthesis planning (CASP),
specically retrosynthetic analysis have gained considerable
interest in recent years.1 The resurgence of articial intelligence
(AI) in computer aided drug design (CADD) has driven the shi
from more traditional expert systems, built around a manually
encoded set of reactions as templates,2 to data-driven
approaches.3,4 Recent successes have been reported coupling
neural networks to Monte-Carlo tree search (MCTS),3 and within
reinforcement learning frameworks,5 deviating from more tradi-
tional expert systems.2,6–12 Their ability to rationalize a set of
promising synthetic routes from reaction data, has been realized
in the framework of Design, Make, Test, Analyze (DMTA) cycles,
in which they have played an integral role for coupling to auto-
mation platforms.4 However, despite recent achievements in the
eld to advance predictive capability, little attention has been
paid to the underlying datasets, the size of the dataset required,
an assessment criteria specic to the template prioritization
method and overall model performance.13
Retrosynthetic planning or analysis refers to the technique
used by chemists to recursively deconstruct a compound into itstraZeneca, Gothenburg, Sweden. E-mail:
y, University of Bern, Bern, Switzerland.
tion (ESI) available. See DOI:simpler precursors, until a set of known or commercially available
building blocks is reached.14 Aer an initial pattern recognition
step, a chemist works in the reverse direction, using a knowledge-
base of synthetic transformations (‘synthetic tool-box’) obtained
through years of experience and exposure to a variety of both
successful and failed chemistry,15,16 to intuitively identify and
prioritize a promising set of forward transformations required to
synthesize a given compound. To complement this process,
computer assisted synthesis planning (CASP) tools are desired
that can rapidly consider a vast body of chemical knowledge,
eﬀectively prioritize a set of reactions, and develop synthesis plans
that can be tailored for the domain in which they will be applied.
These have been reviewed extensively elsewhere.1,9–12,17–21 With the
rise of automation,4,22,23 de novo design,24 and more extensive
virtual libraries,25 such a tool has the added requirement that it
must be able to pre-lter compounds prior to synthesis, thus
reducing experimental failure and accelerating Design, Make,
Test, Analyze (DMTA) cycles prevalent in molecular design.1,4,26,27
Herein, we investigate the role of the template prioritization
method and the tree search algorithm derived from the work of
Segler and Waller.3 Template prioritization is framed as a multi-
class classication problem, for which we employ a neural
network which outputs the probability of applying any given
template, henceforth referred to as the policy network. This
constitutes the machine learning (ML) part of the process, which
we couple to a search strategy and decision-making process in the
form of a tree search. Together these constitute an AI driven
model for retrosynthetic planning. We examine this model in the
context of the underlying datasets, pooling from internalThis journal is © The Royal Society of Chemistry 2020
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View Article OnlineAstraZeneca ELN, publicly available USPTO,28 proprietary
Reaxys29 and Pistachio data.30 The overlap and relations between
the datasets are examined. The nal model's performance is
tested on a set of 1731 compounds from a set of 41 virtual
libraries designed at AstraZeneca between October 2017 and
January 2019, in relation to policy network accuracy, percentage
of routes found, and the number of compounds synthesized
experimentally. Thereby, demonstrating the potential use for
such tools in DMTA cycles, and how datasets with known
experimental results can be used to assess model performance
and improvement of CASP tools. As such, we relate our ndings
of model performance to the underlying datasets. Demonstrating
that models built on datasets such as internal or publicly avail-
able data can predict synthetic routes in line with the literature.Results and discussion
Template specication
Templates were extracted using an adaptation of Coley et al.'s
implementation for rule extraction,31 which only contain the
immediate neighborhood of the reaction centers, thus do not
capture the extended environment required to account for
leaving and protecting groups. In addition, the algorithm failed
to account for reactive species, without specication of which, the
reactants would not be regenerated. This has since been cor-
rected by Coley et al. in RDChiral and has been extended in thisFig. 1 Venn diagram showing the overlap of the patent datasets (USPTO
are expressed as being part of the combined dataset. Only 2% of the extr
Reaxys and patent data. All datasets add a unique component to the ove
contributor (4.5%) owing to the comparably lower dataset size. The two p
the diﬀerent time periods covered and the algorithms used for mining th
upon the template extraction strategy used, the speciﬁcity of the templ
tiﬁcation of duplicates/redundancies. Therefore, the percentages expres
of 1.
This journal is © The Royal Society of Chemistry 2020study to encompass ca. 75 functional and protecting groups
commonly used in organic synthesis.32 These were determined by
analysis of frequently used reactions in the underlying datasets.
We found that half of the top 10 templates across all datasets, and
12% of the Pistachio dataset accounted for protections and
deprotections. This value is similar across all datasets examined
in this study and demonstrates the utility of protecting group
strategies in organic synthesis. Furthermore, we determined that
these improvements translate into the model being able to
account for the extended molecular environment for the groups
specied. However, whilst the model can employ protections and
deprotections, their use is not necessarily strategic. Further work
is required to allow the model to learn their most appropriate use
and incorporate them for maximal eﬀect into synthetic route
planning. The model is also limited in that in cannot learn the
form of new protecting and functional groups from additional
data and is restricted to those specied.Reaction datasets and template coverage
Given the variety of data sources, patents (USPTO and Pistachio),
literature and patents (Reaxys), and industrial data (AstraZeneca
ELN), it is interesting to note that a comparable number of
templates were extracted from the Reaxys and patent datasets
(Table 2). However, whilst both template sets are similar in size
they diﬀer in their coverage of the reaction space as highlighted
in Fig. 1. The inclusion of the Reaxys data oﬀers a greater breadth, Pistachio), Reaxys and a subset of AstraZeneca ELN data. Percentages
acted templates are common between all datasets, and 11.6% between
rall dataset, where the subset of AstraZeneca ELN data is the smallest
atent sets diﬀer in content and coverage of the reaction space owing to
e data. These observations and the calculated overlap are dependent
ate (radius 1 in this case), and the subsequent procedure for the iden-
sed hold true for the strategy used in this study and a template radius
Chem. Sci., 2020, 11, 154–168 | 155
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View Article Onlineof unique reaction templates, accounting for 41.1% of the overall
combined dataset. The comparably high number of unique
templates extracted from the combined patents data (32.5%),
suggests that a considerable portion of patents data covered are
not present in Reaxys (7.4% overlap), or that the structural
components that make up the templates are unique to Reaxys.
The exact diﬀerences between the patent coverage of the patent
datasets (USPTO and Pistachio) and Reaxys is not clear with
regards to the templates that can be obtained. Furthermore, the
increased number of structural components and templates
unique to the Reaxys dataset may be a residual artefact of multi-
step reaction pathways. In this regard, we have ltered for all
multi-step reactions, such that they have been removed from the
dataset to the best of our knowledge.
The discrepancy between the two patent sets can be rational-
ized by the time-period over which the data was collected. The
USPTO dataset accounts for reactions published up to September
2016 whereas Pistachio includes reactions until 17th Nov 2017.
Further diﬀerences in the Pistachio and the public USPTO set
arise from the inclusion of ChemDraw sketch data, and text-
mined European patent oﬃce (EPO) patents which are included
in Pistachio. The sketch datamay bemissing agent and condition
details, as they are ‘as drawn’, and do currently not incorporate
information from the accompanying text. Therefore, species that
contribute a changing atom or bond may be absent and would
not be incorporated in the template extraction. As this informa-
tion cannot be included in the templates, the reaction is dis-
carded, and no template is extracted.
The subset from the AstraZeneca ELN data accounts for 1.5%
of unique templates. Additionally, we observe that there is
a greater overlap with Reaxys than the patent data. These do not
necessarily correspond to novel reactions, but rather are an
artefact of the structural diversity present in the AstraZeneca
collection. For instance, the synthesis of a novel lead compound
could have diﬀerent atomic environments around the reaction
center compared to the literature or patent precedent on which
it was based, thus leading to a new reaction template. Similarly,
2% of all templates are common between the datasets, thus
there is a small degree of structural overlap as might be ex-
pected. These observations and the calculated overlap are
dependent upon the template extraction strategy used, the
specicity of the template (radius 1 in this case), and the
subsequent procedure for the identication of duplicates/
redundancies. Therefore, the percentages expressed hold true
for the strategy used in this study and a template radius of 1.
Additionally, they are an upper bound estimate for the template
overlap given the template extraction strategy used in this study,
and the error associated with the redundancy identication
method, as not all duplicates may have been removed.Neural-network guided template-based retrosynthetic
planning
Neural-network guided template based retrosynthetic planning
methodologies were rst pioneered by Segler and Waller.3,33
They trained three separate networks: an expansion policy
which predicted a set of templates to be applied for a given156 | Chem. Sci., 2020, 11, 154–168compound, a rollout policy which predicted a stricter and more
specic set of templates to be applied for a given compound,
and an in-scope lter trained on positive reactions and a virtu-
ally enumerated set of negative reactions. In contrast, this study
eliminates the expansion and in-scope lter policies, and
focuses on a “naive” baseline retrosynthetic model using only
a network inspired by that termed rollout policy by Segler and
Waller.3
The network predicts which template to use given
a compound, and a set of precursors is generated from the
application of the template. This is then recursively applied to
generate a retrosynthetic tree. The three primary conditions
that must be fullled for a retrosynthetic route to be valid in this
study are as follows. Firstly, there must be a template that has
been extracted from the dataset which can be predicted for
a given context.
Secondly, the predicted template can be successfully applied.
Where successfully applied is dened as: the application of
a template in silico that generates a set of precursors/reactants.
The “success” is in reference to there being subgraph match
between product and template, which enables the generation of
a set of precursors, and does not reect whether a reaction will
be successful (that the reactants generated by application of the
template will form the product) in the wet lab. Additionally, the
set of precursors are required to be valid SMILES. It is native to
the template-based approach that application of a template to
the product or queried compound preserves the global structure
of the compound and only alters that of the reactive site,
therefore in this context it is implied that a valid SMILES also
constitutes a valid set of reactants sharing the same structural
features as the product. However, these are not necessarily
viable precursors in the sense that they are devoid of selectivity
issues and will work in the wet lab. This is a limitation we have
found that is inherent to the template-based methodology and
in some cases originates from the underlying dataset from
which the templates were extracted, as this “error” is carried
forward.
While the ultimate task is to predict synthesis that will work
in the wet lab, we draw a distinction in this study by attempting
to rst determine what can be predicted in silico. To this end, we
view the goal of the neural network policy as being the maxi-
mization of the number of templates that can be applied.
Thereby, enumerating all possible disconnections that fall
within the top 50 predicted templates for a given compound.
Finally, the terminal state of a route is determined by checking
if the enumerated precursors are commercially available.
However, this is not to say that they are devoid of reactivity
conicts, the identication of which is le to reaction predic-
tion models that are not implemented in this study.Template size and policy network accuracy
In previous studies, accuracy has been used as a metric to gauge
the network's performance for the task of retrosynthetic plan-
ning.3,33,34 The accuracy of the policy network reects its ability to
correctly predict a reaction template. However, for the task of
retrosynthetic planning the aim is to predict several applicableThis journal is © The Royal Society of Chemistry 2020
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View Article Onlinetemplates, not just the one recorded in the dataset. Given the
underlying data describes a one to one mapping of product to
template and the task is to predict a one product to many
templates' relationship. High accuracy values are associated with
the model's ability to predict the template or reaction center from
which it was originally extracted, thus overtting the data by
creating a like for like mapping to the underlying dataset. Addi-
tionally, the accuracy does not account for the applicability of the
predicted template, for which we and others have found high
failure rates owing to an inability to match the template
substructure to the target for which it was predicted.5 This is
illustrated in Fig. 2, whereby the increased specication of the
molecular environment surrounding the reaction center (radius)
leads to a higher rate of failure for its application, and translates
to decreased model performance. In contrast, the test accuracy
does not highlight the extent of the performance decrease, but
rather increases as more of the environment surrounding the
reaction center is considered, thus is misleading.
We propose that in conjunction with the accuracy, the more
task- specic measure of the number of applicable templates be
used for policy assessment, and a more holistic view be taken of
overall model performance. In all datasets examined, on
average less than 1% of all templates were applicable for any
given compound. Whereby, only ca. 0.00035% of all templates
were applicable and in the top 50 templates prioritized by the
network for any given compound. Increasing template speci-
city further reduces the number of templates that can be
applied in a given context. Therefore, to balance specicity with
generalizability we propose that templates considering the
reaction center and the rst degree nearest neighbors be used,
in conjunction with the specication of a variety of functional
and protecting groups, to maintain chemical integrity.The eﬀect of template library size on performance
Fig. 3 shows the top-1 accuracy computed for the hold out test
set for a range of library sizes using templates obtained from theFig. 2 (a) The number of predicted templates that can be successfully ap
randomly selected compounds from ChEMBL. The number of predicted
template speciﬁcity. Only ca. 34% of the top 50 templates are applicable o
of 1. (b) Comparison of the top-1 accuracy on the test set, to overall perfo
a set of 1731 compounds from 41 virtual libraries (AZ Virtual Libraries),
pharmaceuticals). The top-1 accuracy on the test set is not reﬂective of
contrast, the overall performance of the model decreases with increased
pharmaceuticals datasets.
This journal is © The Royal Society of Chemistry 2020USPTO dataset, as compared to the ability to predict full
synthetic routes to 1731 compounds in a series of 41 virtual
libraries designed at AstraZeneca. We observed that the accu-
racy decreases with increasing template library size, where the
size of the template library reects the top N templates in the
USPTO dataset. In comparison the average predictive ability of
the model increases, reecting a more task specic measure of
model performance. Where predictive ability refers to the ability
of the baseline retrosynthetic model (policy network combined
with tree search) to generate a retrosynthetic route. In this
context the predicted route is not assessed for ‘quality’ by use of
more powerful reaction prediction models,35 or comparison to
existing literature in an automatic fashion, but rather is
a reection of whether a retrosynthetic route can be proposed in
silico from reaction datasets.
Of note is the increasing diﬀerence between the accuracy
and overall predictive performance as the library size increases.
Whilst the test accuracies have been measured for a baseline
template-based CASP tool, template-free models are also prone
to misleading accuracy values. In both cases the task is to
predict a series of viable outcomes, however the accuracy
reects the ability to predict the ‘ground truth’ from the
underlying dataset, which inherently accounts for only one
‘true’ value, thus is partially known. In a similar work, Segler
and Waller used the top 1, 10 and 50 accuracies to gauge the
performance of their network, and showed that a model trained
on 17 134 rules extracted from Reaxys, covering 52% of the
dataset, was able to predict the reaction center with accuracies
of 50.1%, 89.1%, and 96% respectively.3 In an extension of the
work considering only single step reactions Baylon et. al. re-
ported an accuracy of 81% on 129 rules compared to 83% on
137 rules by Segler and Waller.33,34 However, we have found that
accuracy can be misleading when used for the assessment of
overall model performance as shown in Fig. 2 and 3, and
specically for the assessment of whether the network is able toplied to generate suitable precursors, as determined for a set of 20 000
templates that can be successfully applied decreases with increasing
n average in the best case, for themost general templates with a radius
rmance with respect to the ability to generate full synthetic routes, for
and the top 125 small-molecule therapies of 2018 by sales (top 125
overall model performance and increases with template speciﬁcity. In
template speciﬁcity as demonstrated for the virtual library and top 125
Chem. Sci., 2020, 11, 154–168 | 157
Fig. 3 The template libraries were obtained by ﬁltering the USPTO dataset for templates occurring a minimum of 1, 2, 3, 5, 10, 20, 35, 50, 75, and
100 times. A model was trained on each library and the results are shown for: (a) the top-1 accuracy on the test set, as compared to the overall
performance. The overall performance is with respect to the ability to predict full synthetic routes to a set of 1731 compounds from 41 virtual
libraries designed at AstraZeneca. The experimental average refers to the percentage of compounds synthesized out of those sent for synthesis
after reﬁnement of the virtual library. The accuracy decreases with increasing template library size, whereas the overall predictive performance
increases up to a library size of the 77 281 most frequently occurring reactions. (b) The virtual library set can be further broken down into libraries
designed using a ‘combinatorial’ approach, and a broader set of reactions using more ‘bespoke’ chemistry. The overall model performance
increases marginally for the ‘combinatorial’ libraries with increasing template library size. Whereas, the libraries requiring more ‘bespoke’
chemistry for their synthesis beneﬁt from the inclusion of additional reactions.
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View Article Onlinecorrectly predict applicable reaction templates for single step
reactions.
The virtual library set can be further broken down into
libraries designed using a ‘combinatorial’ approach, and
a broader set of reactions using more ‘bespoke’ chemistry,
which covers the reaction space more extensively. This enabled
consideration of domain dependency with respect to template
library size. We found that virtual libraries designed using
a combinatorial approach beneted marginally from increasing
the template library size. With the 1064 most frequently
occurring templates in the USPTO dataset, routes could be
found for 65% of the compounds in the virtual libraries
designed using a combinatorial approach. This increased to
a maximum of 72% when the 25 126 most frequently occurring
templates were used. This is in line with what would be ex-
pected, as combinatorial libraries employ frequently used and
robust reactions in their design.
In contrast, route predictions for libraries designed with
a broader range of chemistry in mind, denoted ‘bespoke’,
benet from a larger template library size which covers the
reaction space more extensively. Using the 1064 most
frequently occurring templates in the USPTO dataset, the
model predicted synthetic routes to 50% of the compounds in
the ‘bespoke’ library, increasing by 19% to a maximal value of
69% when using 77 281 reaction templates. This alludes to the
point that increasing the number of templates increases the
chemical diversity of the templates, thus more synthetic routes
can be found than with smaller template library sets. The158 | Chem. Sci., 2020, 11, 154–168increase in diversity of the templates originates from the fact
that no two templates are the same, as they account for
diﬀerent sub-structural patterns. Increasing the template
library size, also increases the probability of nding a sub-
structural match to the product to which the template is
applied. On the other hand, the ‘combinatorial’ libraries are
less diverse, arising from the fact that a limited number of
reactions were used to make them. Therefore, templates
matching sub-structural patterns occurring within ‘combina-
torial libraries’ are also limited. There is a balance between the
number of reaction templates and the reaction space they
represent, which is specic to the domain in which the tool is
applied. However, increasing the number of reaction
templates also introduces noise. This can be seen in Fig. 3,
where the overall predictive performance falls by 4% and 6%
for the ‘combinatorial’ and ‘bespoke’ libraries respectively,
when increasing the template library size from 77 281 to
285 018 reaction templates. Furthermore, increasing the
number of reaction templates to those that occur less
frequently (less than 3 times), increases the diﬃculty of
identifying suitable templates. The increased diﬃculty more
than oﬀsets the increased coverage of the reaction space
(Fig. 3).
Compared to the experimental results for each virtual
library, we found that the model consistently over-predicted the
number of compounds that could be synthesized for the
‘combinatorial’ library. Whereas, the number of compounds
that could be synthesized for the ‘bespoke’ library wasThis journal is © The Royal Society of Chemistry 2020
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View Article Onlineconsistently under-predicted. This highlights that only consid-
ering the number of compounds for which routes can be pre-
dicted does not aﬀord enough granularity for the assessment of
synthetic routes, and CASP tools. For instance, it is likely the
baseline retrosynthetic model examined in this study may over
predict the number of compounds that can be synthesized from
the ‘combinatorial’ library, because some of the predicted steps
may not translate to the wet lab. Further still, the conditions
required to carry out the reaction in the forward direction are
not predicted by the model, nor is there any certainty that they
would yield an outcome in the wet lab if predicted. This task is
le to separate models that have not been implemented in this
study, that attempt to predict conditions for a queried set of
substrates and a given transformation.36
The under-prediction of retrosynthetic routes to compounds
that were experimentally obtained in the ‘bespoke’ libraries,
raises questions as to the coverage of the reaction space covered
by the templates, and the ability of the policy network to
prioritize suitable templates. Fig. 3 examines the performance
for a model trained on the USPTO dataset, thus it can be
envisaged, based on Fig. 1 that inclusion of the Reaxys dataset
may improve the result obtained by enabling the prediction of
templates missing from the USPTO data. However, as alluded to
by Fig. 3, this may increase the diﬃculty in identifying suitable
templates, therefore improvements in the policy networks may
be required for a higher number of routes to be found. The
number of routes suggested by this methodology will be an
upper bound estimate, which will decrease as measures are
taken to increase the ‘quality’ of the suggested routes through
incorporation of reaction and condition prediction models.
Furthermore, the reasons for a ‘failed’ synthesis are not
always known and can be dependent on the nature of the
project, the skill of the chemist, and the conditions used, to
name a few factors inuencing the outcome of a synthesis.
These factors cannot always be quantied or considered quali-
tatively, thus both the predictions and ‘true’ experimental
results have an associated degree of uncertainty which proves
diﬃcult to measure.Datasets and performance
We compared the predictive performance of models trained on
each reaction dataset, and combinations thereof, on 1731
compounds from 41 virtual libraries at AstraZeneca and the top
125 small molecule therapies of 2018 (Fig. 4). The models,
regardless of reaction dataset, consistently over-estimate the
number of compounds that can be synthesized in the case of the
virtual libraries, and under-estimate with regards to the top 125
small molecule therapies. For both cases, the average number of
steps taken to synthesize amolecule is 4, however the average time
taken to solve each molecule varies considerably with the dataset
size (Fig. 4). The smaller datasets are faster at nding routes to
a given compound (<4 seconds) owing to a smaller search space in
comparison to the larger search spaces associated with the larger
datasets (Pistachio and Reaxys). The simple architecture used is
not able to handle the large search space and is biased towards
frequently occurring reactions, which are augmented by theThis journal is © The Royal Society of Chemistry 2020additional data in the larger sets. In the case of the top pharma-
ceutical compounds, the lower predictive performance may arise
from more sophisticated ring systems, and natural product like
structures upon which the nal compound is based. Reactions of
this nature are not prioritized by the network as they are infre-
quent, thus become diﬃcult to separate from the noise. Whereas
predictive performance on the virtual library dataset is higher
than that for the top 125 small molecule therapies of 2018 across
all datasets, as they make use of the most frequently employed
reactions.
The average number of successfully applied templates of the
top 50 predicted templates for one-step synthesis per
compound varies considerably across the reaction datasets
examined (Fig. 4). The model built on a subset of the AstraZe-
neca ELN appears to be worse than the models built on other
reaction datasets by this measure. However, we have found that
the number of options the network suggests for one-step
synthesis does not impact overall model performance in this
case. Thus, as Segler and Waller suggested in a previous study
examining training set size,33 models competitive with those
built on larger reaction sets can be obtained with datasets as
small as an internal ELN. The subset of the AstraZeneca ELN
accounts for 4.5% of the template library obtained from
a combination of all datasets examined, yet is capable of
providing suﬃcient training data to train policy networks and
resulting models which are competitive with those of larger
proprietary datasets. However, we expect that this is domain
specic and reects that the subset of the AstraZeneca ELN is
tailored to the medicinal chemistry domain in comparison to
the patent and Reaxys datasets, which are more extensive in
their converage (Fig. 1). This further demonstrates that there is
a balance between the type of chemistry covered by the template
library set, and the size of the template library. An optimal set
would be domain specic, and cover enough examples of
suﬃcient diversity, that the output space would be managable
by the policy network. In the current approach we have found
that as the dataset size increases, so does the output space of
the policy network (Table 2). This increases the time taken to
train the network, and makes it increasingly diﬃcult for the
network to prioritize appropriate reactions as seen when
increasing template library size in Fig. 3.
Previous studies have demonstrated that models built on the
USPTO dataset, can predict one-step synthesis. We show that
despite the seemingly lower amount of data in the USPTO
dataset compared to Reaxys (Table 2). The USPTO dataset
accounts for 44.8% of the template library obtained from
a combination of all datasets examined, in comparison to
53.7% which comes from Reaxys. Whilst there is a 8.9%
diﬀerence and the coverage of the reaction space that the
templates encode varies (Fig. 1), this does not appear to be
a limiting factor for route prediction in the medicinal chemistry
domain. Fig. 4 shows that the model trained on Reaxys
marginally outperforms that trained on the USPTO dataset, at
the expense of longer prediction times. Furthermore, we show
that as the size of the dataset increases to a combination of both
Reaxys and the combined patents data (USPTO and Pistachio),
the overall performance of the model decreases with regards toChem. Sci., 2020, 11, 154–168 | 159
Fig. 4 (a) The average number of successfully applied templates of the top-50 predicted templates for one-step synthesis per compound (b) the
overall predictive performance with respect to the ability to generate full synthetic routes (c) the average number of steps taken per prediction
per compound (d) the average time taken to predict a full synthetic route per compound, as found for each reaction dataset, for a set of 1731
compounds from 41 virtual libraries designed at AstraZeneca and the top 125 small molecule therapies by sales in 2018. The number of predicted
templates that can be successfully applied for one-step synthesis does not correlate to the model's overall ability to generate full synthetic
routes, when comparing between diﬀerent template library sources (datasets). Whilst the model built on the subset of the AstraZeneca ELN
suggests the lowest number of possible options at each step, the overall performance is comparable to, or exceeds models built on the larger
reaction datasets. Thus, a model built on 4.5% of all templates considering all the datasets combined, can predict synthetic routes to compounds
equally as well as the larger datasets examined.
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View Article Onlineboth time and number of routes identied. This may reect the
decrease in performance observed in Fig. 3b, whereby
increasing the number of templates increased the diﬃculty for
the network to prioritize suitable templates.160 | Chem. Sci., 2020, 11, 154–168We noted that the ngerprint size used to encode the
product had a marginal eﬀect on the ability of the model to
predict full synthetic routes for the internal virtual library
dataset (ESI†). In addition, we found that increasing the size ofThis journal is © The Royal Society of Chemistry 2020
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View Article Onlinethe stock library to include the ACD catalogue, increased the
ability of the model to predict full synthetic routes to
compounds in the virtual library. For both the ‘Combinatorial’
and ‘Bespoke’ libraries, the model was able to reduce the
average time taken to predict full synthetic routes with the ACD
catalogue, as well as reduce the average number of steps by one.
The reduction in the average number of steps is more
pronounced for the ‘Bespoke’ libraries, whereby it is consistent
over both the USPTO and Reaxys datasets. This is in comparison
to the ‘Combinatorial’ libraries whereby the reduction in the
number of steps is not observed for the combined Reaxys and
patent data (ESI†).Comparison of test and reaction datasets
Fig. 4 compared the performance of models built on a range of
reaction datasets with two compound sets. A set of 1731
compounds obtained from internal AstraZeneca virtual
libraries, and a set of the top 125 pharmaceutical compounds by
sales in 2018. The former AstraZeneca virtual libraries can be
viewed as general medicinal chemistry targets, given that there
is no or little overlap with the reaction datasets (Table 1), to
which the algorithm is able to generalize as shown in Fig. 4.
Whereas, the top 125 pharmaceuticals are well-known targets in
the training domain, given the much greater overlap with the
underlying datasets (Table 1).
We found that the baseline retrosynthetic model examined
in this study can generate retrosynthetic routes for
compounds outside it's training domain. While these routes
may not necessarily be feasible in the wet lab, they can be
viewed as ideas upon which a trained chemist can build.
Alternatively, the algorithm may help to identify building
blocks and precursors to a target compound that were previ-
ously not considered. In this regard, the quality of the retro-
synthetic routes generated has not been assessed and is le to
manual inspection.Table 1 Percentage overlap of compounds in each of two compound
datasets, AZ virtual libraries and top 125 pharmaceutical compounds
by sales in 2018, with those reported as products in each of the
reaction datasets. As expected, the top 125 pharmaceuticals have
a much greater overlap with the products in each of the reaction
datasets in comparison to the AZ virtual library compounds. This is
because they are patented compounds with a literature precedence
where both the patent and literature examples predate the most
recent timepoints in the underlying dataset. Furthermore, the AZ
virtual library compounds do not overlap with the literature and patent
datasets and lie outside the training data
Dataset
AZ virtual
libraries (%)
Top 125
pharmaceuticals (%)
USPTO 1976–2016 0 47
Pistachio Nov 2017 0 58
Combined patents 0 58
Reaxys 0 70
Reaxys + patents 0 78
AZ ELN subset 2 4
This journal is © The Royal Society of Chemistry 2020Exemplary synthetic routes
Comparison to existing literature in the domain showed that
the model trained solely on the USPTO dataset was competitive
with that reported in the literature (Fig. 5), and was able to nd
a route to the target compound in 4.26 seconds.3 This was also
observed for models trained on the subset of the AZ ELN,
Pistachio and Reaxys datasets. We found that the model was
able to suggest an alternative route in addition to that reported,
involving a ring formation (Fig. 5). Furthermore, we show that
the model can predict routes to the top 125 pharmaceutical
products, where the performance is dependent on the stock set
of compounds. Examples of which have been given in the ESI.†
The route predicted using the model trained on the USPTO
dataset to Amenamevir is compared to the literature route.37
Both routes vary in the order of the steps they take, with the
predicted route preferring a standard amide coupling over the
amide Schotten–Baumann. However, the predicted route
displays reactivity conicts as deprotonation of the amine in the
second step competes with the amide coupling. A further
selectivity issue is present in the rst disconnection step pre-
dicted for Amenamevir, as there will be competition between
the nitrogen in the secondary amine and the amide. This is not
the case for the literature route due to the ordering of the steps.
Selectivity issues are also observed in Fig. 5a for the last retro-
synthetic step (rst step in the forward synthesis) where there is
competition between the –OH and alkyne C–H in the aromatic
nucleophilic substitution. While we know the model to be
capable of using protecting groups, these are not necessarily
used in a strategic way, nor is their appropriate use always
identied.Conclusions
We have developed and implemented a baseline retrosynthetic
tool with only a single neural network, to investigate the role of
the ML template prioritization method in the tree search algo-
rithm derived from the work of Segler and Waller.3,33 We have
found that models trained on datasets as small as the internal
ELN (4.8% of all templates) and USPTO datasets (44.8% of all
templates), are suﬃcient for the prediction of synthetic routes
to compounds found in medicinal chemistry pipelines.
Furthermore, we demonstrated the potential use for such tools
in compound selection and prioritization in DMTA cycles and
suggest that datasets with known experimental results can be
used to assess model performance.
In addition, we demonstrate that accuracy can be
a misleading measure for the performance of the policy
network and nal tree-search model. Thus, we propose an
alternative approach to assessing the ability of the policy
network to identify and maximize the number of templates
that can be applied, based on the number of templates that
can be successfully applied in the top N predictions, for
a given context. We demonstrate that the specicity and
generalizability of the extracted templates must be balanced
such that, the rst degree nearest neighbors to the reaction
center, are used in conjunction with the specication ofChem. Sci., 2020, 11, 154–168 | 161
Fig. 5 (a) Comparison to the exemplary synthesis shown by Segler and Waller.3 The model trained on the USPTO dataset, ﬁnds an alternative
route to that in the previous study, and ﬁnds synthetic routes to the target compound in 4.26 seconds. The model can prioritize and apply ring
formations as demonstrated in step 4. (b) Comparison of the route found by the model trained on the USPTO dataset with the literature route for
Amenamevir.37 Themodel can suggest a route comparable to the literature, diﬀering in the sequence of steps and using similar reactions to those
in the literature. The predicted route is found in 3.26 seconds.
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View Article Onlinefunctional and protecting groups that are common in organic
chemistry.
We have found there is a dependence between the size and
content of the template library used, and the domain in which
it is applied. We found that syntheses of compounds origi-
nating from combinatorial libraries could be predicted using
the most frequently occurring reactions. In contrast,
compounds originating from libraries requiring more
complex syntheses, required an expanded template set for
their successful prediction. Further work is required to make
use of the broad selection of reactions available to improve the
variety and complexity of routes suggested. Further investi-
gations into the template extraction process are also required
to determine their descriptive limits and how this translates
into route prediction.162 | Chem. Sci., 2020, 11, 154–168Methods
Reaction datasets and template extraction
Of the datasets used, only the United States Patent Oﬃce
extracts (USPTO) ranging from the years 1976 to 2016 is publicly
available.28 This is split into granted and applied patents and is
openly available for use by the community. A subset of the
AstraZeneca Electronic Notebooks (ELN) were mined (May
2019) to yield the internal proprietary dataset, considering only
positive reactions, classied as those with a yield greater than
1% and having a conclusion statement. The Pistachio (2017-11-
17)30 and Reaxys29 datasets are commercially available, provided
by NextMove soware and Elsevier respectively under licensing
agreements. The Reaxys dataset was ltered for multi-step
reactions to yield only the intermediate single step records forThis journal is © The Royal Society of Chemistry 2020
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View Article Onlinewhich templates were extracted. Full details of the number of
reactions and unique extracted templates can be found in Table
2.
All reactions were atom-mapped and classied using the
commercially available Filbert and HazELNut packages (v. 3.1.8)
provided by NextMove soware.38 These were subsequently
processed using RDKit and RDChiral for template extrac-
tion,32,39 in conjunction with a custom reaction class developed
by the authors to facilitate reaction processing. The reactions
are parsed as reaction SMILES,40 along with the ID linking back
to the data source, and classication code or textual classica-
tion obtained from the NameRxn soware.41 The reaction
SMILES are of the form:
reactant1$reactant2$reactantn > agent1$agent2$agentn
> product1$product2$productn
where the reactants, agents, and products are separated by ‘>’
and the individual non-covalently bound species represented by
a ‘$’ according to the Daylight SMILES specication.42 The
denition of reactant and agent is ambiguous, as agents may
participate in the reaction and contribute mass to the products.
Additionally, as the templates are extracted based on atom-
mapping, only the species contributing to the product or
changing during the reaction were considered in the process.
Thus, we have moved all agents into the reactants to give
a reaction SMILES of the form:
reactant1$reactant2$reactantn$agent1$agent2$agentn
[ product1$product2$productn
Through string manipulations, the reaction SMILES were
split into their component parts on the ‘[’ ensuring that the
number of parts did not exceed three, one for each, reactants,
agents, and products. Reactions leading to more than one
product, incomplete reactions (i.e. missing reactants or prod-
ucts), or reactions in which the reactants and product wereTable 2 Datasets used in this study and their respective sizes, given as t
Dataset Dataset size
Extracte
validate
USPTO 1976–2016a (ref. 28) 3 748 191 3 079 35
Grantsa 1 808 938 1 471 08
Applicationsa 1 939 254 1 608 26
Pistachio Nov 2017b 6 836 027 4 897 30
Combined patents 10 587 618 7 976 65
Reaxysb 6 540 786d 5 071 07
Reaxys + patents 17 128 404 13 047 7
AZ ELN subsetb,c 398 779d 254 468
All combined 17 523 783 13 302 1
a Publicly available. b Proprietary. c Only successful reactions have been
curation step. Dataset size: refers to the number of reactions available
otherwise specied. Extracted and validated: refers to the number of rea
validation of the extracted template by application to the product of the r
reactants can be regenerated. Duplicates were identied as identical reac
and atom-mapping. Duplicate templates were identied in the same
reactions, where duplicates have been removed.
This journal is © The Royal Society of Chemistry 2020equivalent were removed. Equivalence was determined by con-
verting the reactants and products to InChI and comparing.43
Permutations in the ordering of reactants and products were
accounted for, however this was not signicant in this case as
we only account for reactions with one product.
Reaction templates were extracted as SMIRKS patterns using
RDChiral,32 which we modied to consider an additional ca. 70
commonly occurring functional and protecting groups as
determined by an analysis of the underlying datasets and
extended to commonly used protecting groups in the wider
literature.44,45 These are automatically identied through
a substructure search of the encoded protecting groups and
included in the templates alongside the reaction center and rst
degree nearest neighbor atoms. The reaction center is dened
as atoms and bonds that change during the reaction. Owing to
the number of variations sharing the same core structure for
some protecting groups i.e. silyl ethers, esters, but varying in
alkyl chain length, we have refrained from an exhaustive
encoding of all possible protective groups. Rather, we have
focused on those we found to be commonly occurring in the
dataset and cover the main form of the protecting group,
leaving the decision of the exact form to the chemist.
The extracted templates were parsed and checked for validity
in RDKit,39 following which the template was applied to the
product of the reaction from which it was extracted to deter-
mine if an outcome could be generated. The outcomes were
assessed using the denitions shown in Fig. 6, and the quality
of the template extraction process quantied.
The reactions and resulting templates were hashed individ-
ually following a hashing scheme developed by the authors
inspired by the reaction InChI (Fig. 7).46 This was also used to
identify duplicate reactions and templates and can be used as
an identier for database lookups.
The datasets used in this study and their respective sizes,
given as the raw dataset size without ltering are shown in Table
2. To our knowledge, the combined dataset is the largest re-
ported to date. To enable clarity in the task specic curationhe raw dataset size without ﬁltering
d and
d Without duplicates Templates extracted
1 1 201 602 302 282
8 895 436 239 895
3 923 765 223 871
0 1 627 792 367 488
1 1 711 330 358 307
4 4 571 364 361 603
25 6 141 875 665 288
207 868 30 805
93 6 342 331 675 530
considered. d Values reported are those aer an initial internal data
as reaction SMILES before curation or subsequent ltering, unless
ctions that remain aer curation, automatic template extraction, and
eaction from which it was extracted, to determine if the corresponding
tion SMILES considering variations in the ordering of diﬀerent entities
manner. The number of products refers to products of single step
Chem. Sci., 2020, 11, 154–168 | 163
Fig. 6 (Left) Comparison of the quality of the extracted templates across the available datasets with respect to their ability to regenerate the
reactants of the reaction from which the template was extracted. (Right) Schematic of the categorization criteria used for determining the
reaction templates selectivity, which we use as an initial measure of quality. The categories are deﬁned as: (precise) the template can generate
only the reactants from the reaction from which the template was extracted. (Selective) The template generates the reactants from the reaction
from which the template was extracted in addition to other possible precursors that are not part of the original reaction. (Unselective) The
template generates reactants that do not correspond to any of the reactants in the reaction from which the template was extracted. These may
or may not be viable reactants.
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View Article Onlineprocess, the reduction in size through extraction and validation,
followed by duplicate removal has been shown. Extraction
refers to the extraction of reaction templates from the reactionFig. 7 The reaction is initially rearranged to overcome the need for
classiﬁcation between reactants and agents, as the line is often blurred,
and their deﬁnitions are often the source of debate. Atom-mapping is
subsequently removed to overcome the discrepancies between
toolkits, and variances in the positioning of the reactants and agents at
the point of atom-mapping. The reactants and products are converted
to a RDKit mol objects in without separation of the individual species.
Conversion to InChI for the reactants and products respectively is
carried out in RDKit.43,46 This is order invariant and overcomes the issue
of having multiple SMILES representing the same molecular structure.
The resulting InChIs are concatenated and hashed.
164 | Chem. Sci., 2020, 11, 154–168SMILES,40 and validation refers to the application of the
extracted template to the product of the reaction from which it
was extracted, to determine if the corresponding reactants can
be generated. Duplicates were identied as reaction SMILES
consisting of identical reactants, agents, and products, using an
order invariant hashing scheme accounting for variance in
atom-mapping as developed by the authors. Unique reaction
templates were also identied in the same manner.
The overlap of reaction templates extracted from the
respective datasets was ascertained by using the in-built set
methods in Python. We have observed that some of the noise
associated with automatic template extraction originates from
incorrect mapping, text-mining errors, and human-error from
manual curation. There are several variations of these cases
including, incorrect recording of functional groups, incorrect
mapping of reactive components (i.e. substructures present in
the reactive center may also be present in the solvent or
reagents, for instance the incorrect mapping of an amine in
both the reactant and base), accidental extension of alkyl
chains, representation of catalysts and incomplete reactions,
examples of which can be found in the ESI.† Whilst our
approach to curation can identify such inconsistencies and
disregard their associated reactions, further eﬀorts are required
to improve catalyst representation, text-mining, template
SMIRKS generation and atom-mapping.
Policy networks
Template libraries were constructed by ltering the respective
dataset for templates that occurred a minimum of N times. In
all cases duplicate reactions were removed prior to ltering.
Products were represented as extended connectivity ngerprints
(ECFP) with a radius of 2, using the Morgan algorithm in
RDKit.47 Whereas, templates were represented as binarizedThis journal is © The Royal Society of Chemistry 2020
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View Article Onlinelabels in a one-vs-all fashion using the scikit-learn library using
the ‘LabelBinarizer’.48 Both the input ECFP4 and output vectors
were precomputed. Training, validation, and test sets were
constructed as a random 90/5/5 split of the datasets, using
a random state of 42, where the datasets were shuﬄed prior to
splitting. This was conducted using the scikit-learn library.48
The policy networks framed as supervised multiclass classi-
cation problems were trained using Keras49 with Tensorow50
as the backend, the Adam optimizer with an initial learning rate
of 0.001,51 and categorical cross entropy as the loss function
(Fig. 8). The learning rate was decayed on plateau by a factor of
0.5, where the plateau was considered as no improvement of the
validation loss aer 5 epochs. The top 1, 5, 10, and 50 accuracies
were monitored throughout the training process, and the loss
on the validation set was used with early stopping (patience 10)
to determine the number of epochs for which the model was
trained.Assessing the number of successfully applied templates of the
top N predictions
A random subset of 200 and 20 000 compounds from ChEMBL
(v. 24.1)52 were used to assess the baseline number of applicable
templates and the applicability of the top N templates respec-
tively, unless otherwise stated. Salts were removed from the
ChEMBL dataset using RDKit.39 Random subsets were drawn
from the resulting dataset using a random state of 1.
The model to be assessed was loaded into Keras and the
compounds to be queried converted into ECFP4 ngerprints
prior to passing to the model for prediction. The top N predic-
tions sorted in order of decreasing probability were used for
each compound. The templates were applied to the compound
in turn using RDChiral to determine if an outcome was gener-
ated. Templates leading to an outcome were classed as
successful.Fig. 8 Architecture used to train the ‘rollout’ policy taking molecules
represented as ECFP4 as input, through a fully connected layer of 512
nodes, ELU as the activation function, and L2 regularization set at
0.001. Followed by a dropout of 0.04 and softmax output layer.
This journal is © The Royal Society of Chemistry 2020Tree search with 1N-MCTS
The tree search was implemented as a simplication of the
algorithm described by Segler et al.3 The MCTS algorithm was
simplied with regards to the policy network. The same network
was used for both the expansion and the roll-out. The prior
probabilities were not used by default during the selection of
leaf nodes for expansion, but the Q value was initialized at 0.5
and N at 1, as expansion counts as a rst visit.Algorithm
The search tree is built up from nodes that contain states with
current molecules of the route. The root node contains one
molecule, which is the target molecule of the algorithm. Other
nodes can contain states with one or more molecules. Each
node is bound to others in a directed way as parent-child nodes,
with actions as edges. The action is the retrosynthetic reaction
performed on one of the molecules of the parent state, to yield
the molecules of the child node state. The search algorithm
starts with the expansion of the root node (see below).Selection of leaf node
In each iteration the search tree is traversed using the upper
condence bound (UCB) scores of the nodes (eqn (1)).53 Starting
from the root node, the UCB scores of the children are
calculated.
UCB ¼ Q
N
þ C 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2 ln N1
N
r
(1)
Here Q is the current sum of previous rewards. N is the number
of times the child state has been visited, N1 is the number of
times the parent state has been visited. C is a tunable parameter
balancing exploitation and exploration which was set to 1.4 by
default. If the selected child is already expanded (i.e. has child
nodes), the UCB scores of these are then calculated and the next
child selected in an iterative way until an unexpanded leaf node
is selected. Actions are stored at the parent level, and the child
nodes are rst instantiated as node objects by applying the
associated action when visited (see below).Expansion of node
Expansion is performed by employing the expansion policy
neural network for each of the molecules present in the state of
the selected node. The top scored reaction templates are ltered
to retain the top 50 or until a cumulative policy network score of
0.995 is reached. The possible actions (molecule + reaction) for
all molecules are stored at the parent level, and vectors of
associated Q and N values initialized (0.5 and 1 respectively).
The action with the highest UCB score is selected for the roll-
out. In case of multiple actions sharing the largest score,
random selection is performed. The child state is instantiated
and added to the search tree by employing the associated
reaction template to the molecule specied in the action using
RDKit.39 In case the reaction did not give any output, the action
Q is given a value of 106, eﬀectively preventing reselection. IfChem. Sci., 2020, 11, 154–168 | 165
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View Article Onlineno actions are available, the state is marked terminal and the
state evaluated with the reward function (see below).Roll out
No in-scope policy was employed aer the expansion phase. The
roll out policy was identical to the expansion policy and thus
allowed for reuse of the previous roll-outs during tree building
and searching. Expansion of new child nodes during roll out is
similar to the above, except the selection is done by random
among the available actions. Aer each roll-out step the state
was evaluated and the roll out stopped if either the state was
solved (all compounds found in stock) or the maximum tree
depth reached, or no valid actions are available.Reward calculation and back propagation
The reward function for the nal state is then calculated (eqn
(2)) and the score back propagated through the tree, updating
the Q and N values of all parent states between the nal state
and the root state (target compound).
Reward ¼ 0:95 Nin_stock
N
þ 0:05max ðtransformsÞ (2)
N is the total number of compounds in the state, Nin_stock is the
number of compounds that are in stock. Transforms is the
number of transforms each compound has undergone with
respect to the root compound.Iteration and stop of search
Selection of the next leaf node to expand is then instantiated
from the root node, until the maximum number of iterations or
the time limit has been reached. If early stopping is wanted, the
algorithm can stop if any state contains a solved state with all
compounds in stock.Implementation
The algorithm was implemented in an object-oriented archi-
tecture, with a range of global objects for handling the search
tree, the stock, the neural network predictions, settings of
parameters and a logging object. The global objects were
implemented using a Borg pattern that ensures singleton status
and easy access though re-instantiation anywhere in the code.
NetworkX was used to keep track of the parent-child relations
during building of the search tree.54 The stock object keeps the
stock as a set of InChIKeys for fast, hashed tests if compounds
are contained in the stock. InChIKeys were calculated through
the RDKit api for the INCHI soware.43 Nodes and states are
regular python classes, that can have several diﬀerent object
instances. The state object contain information about the
current molecules in that state as well as the number of
conversions each molecule has undergone from the root states
compound. Nodes contain vectors of possible actions and child
Q and N values as well as methods expansion, traversing the tree
and node expansion.166 | Chem. Sci., 2020, 11, 154–168Stocks
A subset of the AstraZeneca internal catalogue and enamine
building block sets were used as the stock set of compounds in
all calculations unless specied. InChIKeys were computed for
all compounds and duplicates removed. The subset of the AZ
internal catalogue was obtained from a database dump of
available compounds (January 2019) and contains 60 530
compounds. The enamine building blocks list was provided by
enamine, January 2019, and consists of 162 194 compounds
aer preprocessing and ltering. The ACD catalogue was addi-
tionally used to provide a more extensive set of stock
compounds.55 The compounds which had a CHIME dened
where an InChIKey could be generated was extracted from ACD
giving a nal stock set of nearly 12.5 million compounds.
Template library size and performance
To study the eﬀect of library size on model performance,
a ltering criterion of templates occurring a minimum of 1, 2, 3,
5, 10, 20, 35, 50, 75, and 100 times was applied to generate the
appropriately sized libraries, and a policy network trained on
each set.
1731 compounds spanning 41 virtual libraries designed at
AstraZeneca between October 2017 and January 2019, and the
top 125 small molecule therapies by sales in 2018 were used to
test the algorithm.56 The virtual library set can be further broken
down into libraries designed using a ‘combinatorial’ approach,
and a broader set of reactions using more ‘bespoke’ chemistry.
Knowledge of the number of compounds sent for synthesis and
the number of compounds successfully synthesized was con-
tained within the dataset. The aim was to couple the policy
network to the tree search to determine for how many of the
compounds a synthetic route could be predicted, and whether it
was reective of experimental results.
Datasets and performance
Each dataset was ltered for templates occurring a minimum of
three times, and a policy network trained on each set. The policy
network was assessed for the number of successfully applied
templates of the top N predictions, where N was 50. Subsequently
the policy network was coupled to the tree search to form the
overall model, which was assessed using the virtual library dataset
and the top 125 small molecule therapies by sales in 2018.56
Availability of data and materials
AstraZenca, Pistachio and Reaxys datasets were used with
permissions. Filbert, NameRxn and HazelNut were used for
atom-mapping and classication under license from NextMove
soware. The implementations source code will be made
available at https://github.com/reymond-group/CASP-and-
dataset-performance.
Funding
Amol Thakkar is supported nancially by the European Union's
Horizon 2020 research and innovation program under theThis journal is © The Royal Society of Chemistry 2020
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
N
ov
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
/9
/2
02
0 
2:
13
:5
6 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineMarie Skłodowska-Curie grant agreement no. 676434, “Big Data
in Chemistry” (“BIGCHEM,” http://bigchem.eu).Author contributions
Amol Thakkar and Esben Jannik Bjerrum designed and con-
ducted the research. Thierry Kogej, Jean-Louis Reymond, and
Ola Engkvist contributed ideas and provided scientic advice.
Esben Jannik Bjerrum, Ola Engkvist and Jean-Louis Reymond
supervised the project.Conﬂicts of interest
The authors declare that they have no competing interests.Acknowledgements
The authors would like to thank Roger Sayle and John Mayeld at
NextMove soware for providing the Pistachio dataset, and for
discussions regarding the datasets. Elsevier for providing the
Reaxys dataset. Nidhal Selmi and Per-Ola Norrby for their
comments and discussions regarding chemistry. Erik Malmerberg
and the virtual screening group at AstraZeneca for the virtual
library dataset. In addition to the Molecular AI group at AstraZe-
neca and Reymond group at the University of Bern for their
support.References
1 O. Engkvist, P.-O. Norrby, N. Selmi, Y.-h. Lam, Z. Peng,
E. C. Sherer, W. Amberg, T. Erhard and L. A. Smyth,
Computational prediction of chemical reactions: current
status and outlook, Drug Discovery Today, 2018, 23(6),
1203–1218.
2 S. Szymkuc´, E. P. Gajewska, T. Klucznik, K. Molga,
P. Dittwald, M. Startek, M. Bajczyk and B. A. Grzybowski,
Computer-assisted synthetic planning: the end of the
beginning, Angew. Chem., Int. Ed., 2016, 55(20), 5904–5937.
3 M. H. S. Segler, M. Preuss and M. P. Waller, Planning
chemical syntheses with deep neural networks and
symbolic AI, Nature, 2018, 555, 604.
4 C. W. Coley, D. A. Thomas, J. A. M. Lummiss, J. N. Jaworski,
C. P. Breen, V. Schultz, T. Hart, J. S. Fishman, L. Rogers,
H. Gao, R. W. Hicklin, P. P. Plehiers, J. Byington,
J. S. Piotti, W. H. Green, A. J. Hart, T. F. Jamison and
K. F. Jensen, A robotic platform for ow synthesis of
organic compounds informed by AI planning, 2019, 365
(6453), eaax1566.
5 J. S. Schreck, C. W. Coley and K. J. M. Bishop, Learning
Retrosynthetic Planning through Simulated Experience,
ACS Cent. Sci., 2019, 5(6), 970–981.
6 J. Law, Z. Zsoldos, A. Simon, D. Reid, Y. Liu, S. Y. Khew,
A. P. Johnson, S. Major, R. A. Wade and H. Y. Ando, Route
Designer: A Retrosynthetic Analysis Tool Utilizing
Automated Retrosynthetic Rule Generation, J. Chem. Inf.
Model., 2009, 49(3), 593–602.This journal is © The Royal Society of Chemistry 20207 A. Bøgevig, H.-J. Federsel, F. Huerta, M. G. Hutchings,
H. Kraut, T. Langer, P. Lo¨w, C. Oppawsky, T. Rein and
H. Saller, Route Design in the 21st Century: The ICSYNTH
Soware Tool as an Idea Generator for Synthesis
Prediction, Org. Process Res. Dev., 2015, 19(2), 357–368.
8 C. D. Christ, M. Zentgraf and J. M. Kriegl, Mining Electronic
Laboratory Notebooks: Analysis, Retrosynthesis, and
Reaction Based Enumeration, J. Chem. Inf. Model., 2012,
52(7), 1745–1756.
9 E. Corey, A. Long and S. Rubenstein, Computer-assisted
analysis in organic synthesis. 1985, 228 (4698), 408–418.
10 E. J. Corey and W. T. Wipke, Computer-Assisted Design of
Complex Organic Syntheses, Science, 1969, 166(3902), 178.
11 D. A. Pensak and E. J. Corey, LHASA – Logic and Heuristics
Applied to Synthetic Analysis. In Computer-Assisted Organic
Synthesis, American Chemical Society: 1977; vol. 61, pp. 1–
32.
12 W.-D. Ihlenfeldt and J. Gasteiger, Computer-Assisted
Planning of Organic Syntheses: The Second Generation of
Programs, Angew. Chem., Int. Ed. Engl., 1996, 34(23–24),
2613–2633.
13 C. W. Coley, W. H. Green and K. F. Jensen, Machine Learning
In Computer-Aided Synthesis Planning, Acc. Chem. Res.,
2018, 51(5), 1281–1289.
14 E. J. Corey, General methods for the construction of complex
molecules. In The Chemistry of Natural Products,
Butterworth-Heinemann: 1967; pp. 19–37.
15 N. Schneider, D. M. Lowe, R. A. Sayle, M. A. Tarselli and
G. A. Landrum, Big Data from Pharmaceutical Patents: A
Computational Analysis of Medicinal Chemists' Bread and
Butter, J. Med. Chem., 2016, 59(9), 4385–4402.
16 A. R. Surrey, Name Reactions in Organic Chemistry, Academic
Press, 2nd edn, 1961, ISBN 978-1-4832-3227-0, DOI: 10.1016/
B978-1-4832-3227-0.50004-3.
17 M. H. Todd, Computer-aided organic synthesis, Chem. Soc.
Rev., 2005, 34(3), 247–266.
18 I. I. Baskin, T. I. Madzhidov, I. S. Antipin and A. A. Varnek,
Articial intelligence in synthetic chemistry: achievements
and prospects, Russ. Chem. Rev., 2017, 86(11), 1127–1156.
19 M. K. Yadav, On the synthesis of machine learning and
automated reasoning for an articial synthetic organic
chemist, New J. Chem., 2017, 41(4), 1411–1416.
20 O. Ravitz, Data-driven computer aided synthesis design,
Drug Discovery Today: Technol., 2013, 10(3), e443–e449.
21 W. A. Warr, A Short Review of Chemical Reaction Database
Systems, Computer-Aided Synthesis Design, Reaction
Prediction and Synthetic Feasibility, Mol. Inf., 2014, 33(6–
7), 469–476.
22 A. Buitrago Santanilla, E. L. Regalado, T. Pereira, M. Shevlin,
K. Bateman, L.-C. Campeau, J. Schneeweis, S. Berritt,
Z.-C. Shi, P. Nantermet, Y. Liu, R. Helmy, C. J. Welch,
P. Vachal, I. W. Davies, T. Cernak and S. D. Dreher,
Nanomole-scale high-throughput chemistry for the
synthesis of complex molecules, Science, 2015, 347(6217),
49–53.Chem. Sci., 2020, 11, 154–168 | 167
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
N
ov
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
/9
/2
02
0 
2:
13
:5
6 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online23 S. V. Ley, D. E. Fitzpatrick, R. J. Ingham and R. M. Myers,
Organic Synthesis: March of the Machines, Angew. Chem.,
Int. Ed., 2015, 54(11), 3449–3464.
24 M. Olivecrona, T. Blaschke, O. Engkvist and H. Chen,
Molecular de-novo design through deep reinforcement
learning, J. Cheminf., 2017, 9(1), 48.
25 M. H. S. Segler, T. Kogej, C. Tyrchan and M. P. Waller,
Generating Focused Molecule Libraries for Drug Discovery
with Recurrent Neural Networks, ACS Cent. Sci., 2018, 4(1),
120–131.
26 A. T. Plowright, C. Johnstone, J. Kihlberg, J. Pettersson, G. Robb
and R. A. Thompson, Hypothesis driven drug design:
improving quality and eﬀectiveness of the design-make-test-
analyse cycle, Drug Discovery Today, 2012, 17(1), 56–62.
27 C. P. Green, O. Engkvist and G. Pairaudeau, The convergence
of articial intelligence and chemistry for improved drug
discovery, Future Med. Chem., 2018, 10(22), 2573–2576.
28 D. Lowe, Chemical reactions from US patents, 1976–Sep 2016,
https://gshare.com/articles/
Chemical_reactions_from_US_patents_1976-Sep2016_/
5104873, accessed 31-04-2018.
29 Reaxys©, Copyright © 2019 Elsevier Limited except certain
content provided by third parties, Reaxys is a trademark of
Elsevier Limited.
30 J. Mayeld, D. Lowe and R. Sayle, Pistachio. 2.0 edn, Soware,
2018.
31 C. W. Coley, R. Barzilay, T. S. Jaakkola, W. H. Green and
K. F. Jensen, Prediction of Organic Reaction Outcomes
Using Machine Learning, ACS Cent. Sci., 2017, 3(5), 434–443.
32 C. W. Coley, W. H. Green and K. F. Jensen, RDChiral: An
RDKit wrapper for handling stereochemistry in
retrosynthetic template extraction and application, J.
Chem. Inf. Model., 2019, 59(6), 2529–2537.
33 M. H. S. Segler and M. P. Waller, Neural-Symbolic Machine
Learning for Retrosynthesis and Reaction Prediction,
Chem.–Eur. J., 2017, 23(25), 5966–5971.
34 J. L. Baylon, N. A. Cilfone, J. R. Gulcher and
T. W. Chittenden, Enhancing Retrosynthetic Reaction
Prediction with Deep Learning Using Multiscale Reaction
Classication, J. Chem. Inf. Model., 2019, 59(2), 673–688.
35 P. Schwaller, T. Laino, T. Gaudin, P. Bolgar, C. A. Hunter,
C. Bekas and A. A. Lee, Molecular Transformer: A Model
For Uncertainty-Calibrated Chemical Reaction Prediction,
ACS Cent. Sci., 2019, 5(9), 1572–1583.
36 H. Gao, T. J. Struble, C. W. Coley, Y. Wang, W. H. Green and
K. F. Jensen, Using Machine Learning To Predict Suitable
Conditions for Organic Reactions, ACS Cent. Sci., 2018,
4(11), 1465–1476.
37 A. C. Flick, C. A. Leverett, H. X. Ding, E. McInturﬀ, S. J. Fink,
C. J. Helal and C. J. O'Donnell, Synthetic Approaches to the
New Drugs Approved During 2017, J. Med. Chem., 2019,
7340–7382.
38 NextMove Soware|HazELNut.
39 RDKit: Open-source cheminformatics, http://www.rdkit.org.
40 D. Weininger, SMILES, a chemical language and
information system, 1. introduction to methodology and
encoding rules, J. Chem. Inf. Comput. Sci., 1988, 28(1), 31–36.168 | Chem. Sci., 2020, 11, 154–16841 NextMove Soware|NameRxn.
42 Daylight Theory Manual, Daylight Version 4.9, Release Date
08/01/11, Daylight Chemical Information Systems, Inc.
43 S. R. Heller, A. McNaught, I. Pletnev, S. Stein and
D. Tchekhovskoi, InChI, the IUPAC International Chemical
Identier, J. Cheminf., 2015, 7(1), 23.
44 P. G. M. Wuts and T. W. G., Greene's Protective Groups in
Organic Synthesis, 4 edn, John Wiley & Sons, Inc, 2006.
45 https://www.organic-chemistry.org/protectivegroups/,
accessed 30-03-2019.
46 G. Grethe, G. Blanke, H. Kraut and J. M. Goodman,
International chemical identier for reactions (RInChI), J.
Cheminf., 2018, 10(1), 22.
47 D. Rogers and M. Hahn, Extended-Connectivity
Fingerprints, J. Chem. Inf. Model., 2010, 50(5), 742–754.
48 F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion,
O. Grisel, M. Blondel, P. Prettenhofer, R. Weiss, V. Dubourg,
J. Vanderplas, A. Passos, D. Cournapeau, M. Brucher,
M. Perrot and E. Duchesnay, Scikit-learn: Machine Learning
in Python, Int. J. Mach. Learn., 2011, 12, 2825–2830.
49 F. Chollet, Keras, GitHub, 2015, https://github.com/fchollet/
keras.
50 M. Abadi, A. Agarwal, P. Barham, E. Brevdo, Z. Chen,
C. Citro, G. S. Corrado, A. Davis, J. Dean, M. Devin,
S. Ghemawat, I. Goodfellow, A. Harp, G. Irving, M. Isard,
Y. Jia, R. Jozefowicz, L. Kaiser, M. Kudlur, J. Levenberg,
D. Mane, R. Monga, S. Moore, D. Murray, C. Olah,
M. Schuster, J. Shlens, B. Steiner, I. Sutskever, K. Talwar,
P. Tucker, V. Vanhoucke, V. Vasudevan, F. Viegas,
O. Vinyals, P. Warden, M. Wattenberg, M. Wicke, Y. Yu
and X. Zheng, TensorFlow: large-scale machine learning on
heterogeneous systems. 2015.
51 P. Diederik and J. B. Kingma, Adam: a method for stochastic
optimization. arXiv pre-prints 2014.
52 A. Gaulton, A. Hersey, M. Nowotka, A. P. Bento, J. Chambers,
D. Mendez, P. Mutowo, F. Atkinson, L. J. Bellis, E. Cibria´n-
Uhalte, M. Davies, N. Dedman, A. Karlsson,
M. P. Magarin˜os, J. P. Overington, G. Papadatos, I. Smit
and A. R. Leach, The ChEMBL database in 2017, Nucleic
Acids Res., 2017, 45(D1), D945–D954.
53 C. B. Browne, E. Powley, D. Whitehouse, S. M. Lucas,
P. I. Cowling, P. Rohlfshagen, S. Tavener, D. Perez,
S. Samothrakis and S. Colton, A Survey of Monte Carlo
Tree Search Methods, IEEE T. Comp. Intel. Al., 2012, 4(1),
1–43.
54 A. A. Hagberg, D. A. Schult and P. J. Swart, Exploring network
structure, dynamics, and function using NetworkX, in
Proceedings of the 7th Python in Science Conference
(SciPy2008), ed. G. Varoquaux, T. Vaught and J. Millman,
Pasadena, CA USA, Aug 2008, pp. 11–15.
55 https://www.acdlabs.com/index.php.
56 J. T. Njardarson, Top 200 Brand Name Drugs by Retail Sales in
2018, https://njardarson.lab.arizona.edu/sites/
njardarson.lab.arizona.edu/les/2018T
op200PharmaceuticalRetailSalesPosterLowResFinal_0.pdf
accessed 30/05/2019.This journal is © The Royal Society of Chemistry 2020
